×
MedSchool: Ace Your OSCEsThe Medical Company
 
 
 
 
 
GET - On the App Store
View
Drug Guide
 
 

Alemtuzumab

 
Bookmark
 View Topic Outline
  •  
    IV
    Alemtuzumab
    MabCampath (CLL), LemTrada (MS) 

  • Mechanism of Action

  • A humanized monoclonal antibody that binds to CD-52 receptors found on mature lymphocytes, initiating complement-mediated and antibody-dependent cell-mediated cytotoxicity.

Clinical Use

  • Indications
  • B cell chronic lymphocytic leukaemia (CLL)
  • Relapsing multiple sclerosis (MS)
  • Adverse Effects
  • Bone marrow suppression - leucopaenia, anaemia, thrombocytopaenia
  • Nausea / vomiting / diarrhoea / anorexia
  • Headache
  • Confusion
  • Hypotension
  • Dyspnoea
  • Arthralgia / myalgia
  • Rash
  • Fatigue
Want more info like this?
  • Your electronic clinical medicine handbook
  • Guides to help pass your exams
  • Tools every medical student needs
  • Quick diagrams to have the answers, fast
  • Quizzes to test your knowledge
Sign Up Now
   
 
 

Snapshot: Initialising...